Ibing S, Cho JH, Bottinger EP, Ungaro RC, et al. Second-Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real-World Propensity Score-Weighted Analysis. Clin Gastroenterol Hepatol 2023;21:2629-2638.
PMID: 36787837